Law Daily Report

GSK Plunges as Drugmaker Must Face Zantac Cases in Delaware

  • 📰 BNNBloomberg
  • ⏱ Reading Time:
  • 18 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 11%
  • Publisher: 50%

Law Law Headlines News

Law Law Latest News,Law Law Headlines

GSK Plc shares slumped in the wake of a court ruling that the UK drugmaker, alongside others including Sanofi, must face trials over whether the former heartburn treatment Zantac causes cancer.

GSK Plunges as Drugmaker Must Face Zantac Cases in DelawareChina’s CNGR Looks to Snap Up More Lithium Projects in ArgentinaMicrosoft Makes $3.

Energy Secretary calls for more nuclear power while celebrating US$35 billion Georgia reactorsThe Daily Chase: GDP comes in softer than expectedThe Daily Chase: Strong numbers from RBC, CIBC cap earnings from big banksCan AI-driven efficiencies address Canada's lagging economic productivity?The Daily Chase: Light trading day on holidays in U.S.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 83. in LAW

Law Law Latest News, Law Law Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

First Zantac Cancer Case to Go to Trial Ends in Win for DrugmakersDrugmakers GSK Plc and Boehringer Ingelheim GmbH persuaded a Chicago jury to reject a woman’s claim that the blockbuster heartburn drug Zantac caused her cancer, handing the companies a win in the first of thousands of such lawsuits to go to trial.
Source: BNNBloomberg - 🏆 83. / 50 Read more »